Skip to main content
. 2012 Apr 23;7(4):e35684. doi: 10.1371/journal.pone.0035684

Figure 2. Loss of P-Smad2C in gastric cancer cells.

Figure 2

(A) Immune positivity of P-Smad2C was significantly decreased in cancer tissues (b) when compared with surrounding normal tissues (a) in 77 out of 130 patients with gastric cancer. Representative pictures were taken from a patient with signet-ring cell carcinoma. (B) In tumor tissues, cancer cells with poor atypia (e–h) showed decreased P-Smad2C staining compared to those with a well-differentiated phenotype (a–d).